Cargando…
Molecular Mechanisms of Treatment Resistance in Glioblastoma
Glioblastoma is the most common malignant primary brain tumor in adults and is almost invariably fatal. Despite our growing understanding of the various mechanisms underlying treatment failure, the standard-of-care therapy has not changed over the last two decades, signifying a great unmet need. The...
Autores principales: | Ou, Alexander, Yung, W. K. Alfred, Majd, Nazanin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794986/ https://www.ncbi.nlm.nih.gov/pubmed/33396284 http://dx.doi.org/10.3390/ijms22010351 |
Ejemplares similares
-
The promise of DNA damage response inhibitors for the treatment of glioblastoma
por: Majd, Nazanin K, et al.
Publicado: (2021) -
Molecular Mechanisms of Drug Resistance in Glioblastoma
por: Dymova, Maya A., et al.
Publicado: (2021) -
Deciphering the Role of Autophagy in Treatment of Resistance Mechanisms in Glioblastoma
por: Khan, Imran, et al.
Publicado: (2021) -
Mechanisms of EGFR Resistance in Glioblastoma
por: Pan, Peter C., et al.
Publicado: (2020) -
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023)